2,7-dibromo-9,9-diphenylfluorene | CAS:186259-63-2

We serve 2,7-dibromo-9,9-diphenylfluorene CAS:186259-63-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,7-dibromo-9,9-diphenylfluorene

Chemical Name:2,7-dibromo-9,9-diphenylfluorene
CAS.NO:186259-63-2
Synonyms:2,7-Dibromo-9,9-diphenyl-9H-fluorene
2,7-dibromo-9,9-dipheneyl fluorene
Molecular Formula:C25H16Br2
Molecular Weight:476.20300
 
Physical and Chemical Properties:
Density:1.548
Boiling point:520.3ºC
Flash point:311.1ºC
Index of Refraction:1.693
 
Specification:
Appearance:Off-white powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 2,7-dibromo-9,9-diphenylfluorene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,7-dibromo-9,9-dipheneyl fluorene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,7-dibromo-9,9-dipheneyl fluorene Use and application,2,7-Dibromo-9,9-diphenyl-9H-fluorene technical grade,usp/ep/jp grade.


Related News: Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.2-Chloro-4-fluorobenzaldehyde manufacturer Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.2-(4-Diethylamino-2-hydroxybenzoyl)benzoic acid supplier Is there a cure? Not at the moment. Researchers have successfully grown the virus in a lab, an important step towards developing a vaccine — but it could be a year or more until it’s available.9-(2-Bromophenyl)-9H-carbazole vendor Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.